Log In
BCIQ
Print this Print this
 

docetaxel (Docetaxel Injection)

  Manage Alerts
Collapse Summary General Information
Company Teikoku Seiyaku Co. Ltd.
DescriptionAlcohol-free formulation of docetaxel, a microtubule-stabilizing taxoid
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard IndicationSolid tumors
Indication DetailsTreat breast cancer, non-small cell lung cancer, prostate cancer, gastric adenocarcinoma and head and neck cancer
Regulatory Designation
PartnerEagle Pharmaceuticals Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today